Teva UK has promoted chief operating officer Kim Innes to general manager of its UK and Ireland business, succeeding Richard Daniell.
Innes brings almost 25 years of industry experience to the role, during which time she served a two-year term as chair of the British Generic Manufacturers’ Association.
She became head of Teva’s generics business unit in the UK in 2006, before taking on her most recent position as chief operating officer in which she played a key role in the company’s acquisition of Actavis Generics.
Innes said: “I am excited to be leading this great organisation at what is a transformational time for both Teva as a company and the pharmaceutical industry as a whole.
“We have an extremely talented group of people here in the UK and Ireland and I am confident that we will continue to maintain our leadership position while keeping an absolute focus on our patients and customers.”